Evidence map›Paper›PMID 39062995›Full record

ArticleInternational journal of molecular sciences2024

Characterisation of Canine and Feline Breast Tumours, Their Metastases, and Corresponding Primary Cell Lines Using LA-REIMS and DESI-MS Imaging.

Adrienn Molnár, Gabriel Stefan Horkovics-Kováts, Nóra Kucsma, Zsuzsanna Szegő, Boglárka Tauber, Attila Egri, Zoltán Szkupien, Bálint András Deák, James S McKenzie, Julianna Thuróczy and 4 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Adrienn MolnárHevesy György PhD School of Chemistry, ELTE Eötvös Loránd University, H-1117 Budapest, Hungary.
Gabriel Stefan Horkovics-KovátsHevesy György PhD School of Chemistry, ELTE Eötvös Loránd University, H-1117 Budapest, Hungary.ORCID 0009-0008-1986-7065
Nóra KucsmaInstitute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, H-1117 Budapest, Hungary.
Zsuzsanna SzegőWaters Research Center, H-1031 Budapest, Hungary.
Boglárka TauberQamcom Central Europe, H-1052 Budapest, Hungary.
Attila EgriWaters Research Center, H-1031 Budapest, Hungary.
Zoltán SzkupienIndependent Researcher, H-1141 Budapest, Hungary.
Bálint András DeákDepartment of Pathology, Forensic and Insurance Medicine, Semmelweis University, H-1085 Budapest, Hungary.
James S McKenzieDepartment of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London W12 0NN, UK.ORCID 0000-0002-1007-317X
Julianna ThuróczyAnimal Health Center Budafok, H-1221 Budapest, Hungary.ORCID 0000-0001-9062-1406
Richard SchäfferWaters Research Center, H-1031 Budapest, Hungary.ORCID 0000-0002-6532-1492
Gitta SchlosserMTA-ELTE Lendület (Momentum) Ion Mobility Mass Spectrometry Research Group, Faculty of Science, Institute of Chemistry, ELTE Eötvös Loránd University, H-1117 Budapest, Hungary.ORCID 0000-0002-7637-7133
Gergely SzakácsInstitute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, H-1117 Budapest, Hungary.ORCID 0000-0002-9311-7827
Júlia BalogWaters Research Center, H-1031 Budapest, Hungary.ORCID 0000-0003-4914-8797

Funding

European Union RRF-2.3.1-21-2022-00015Ministry of Innovation and Technology of Hungary from the National Research, Development and Innovation Fund SNN 138407Slovenian Research Agency J3-3066
6 · The paper itself

Abstract

Breast cancer, a complex disease with a significant prevalence to form metastases, necessitates novel therapeutic strategies to improve treatment outcomes. Here, we present the results of a comparative molecular study of primary breast tumours, their metastases, and the corresponding primary cell lines using Desorption Electrospray Ionisation (DESI) and Laser-Assisted Rapid Evaporative Ionisation Mass Spectrometry (LA-REIMS) imaging. Our results show that ambient ionisation mass spectrometry technology is suitable for rapid characterisation of samples, providing a lipid- and metabolite-rich spectrum within seconds. Our study demonstrates that the lipidomic fingerprint of the primary tumour is not significantly distinguishable from that of its metastasis, in parallel with the similarity observed between their respective primary cell lines. While significant differences were observed between tumours and the corresponding cell lines, distinct lipidomic signatures and several phospholipids such as PA(36:2), PE(36:1), and PE(P-38:4)/PE(O-38:5) for LA-REIMS imaging and PE(P-38:4)/PE(O-38:5), PS(36:1), and PI(38:4) for DESI-MSI were identified in both tumours and cells. We show that the tumours' characteristics can be found in the corresponding primary cell lines, offering a promising avenue for assessing tumour responsiveness to therapeutic interventions. A comparative analysis by DESI-MSI and LA-REIMS imaging revealed complementary information, demonstrating the utility of LA-REIMS in the molecular imaging of cancer.

Indexed as

Breast NeoplasmsMammary Neoplasms, AnimalAnimalsCat DiseasesCatsCell Line, TumorDog DiseasesDogsFemaleLipidomicsNeoplasm MetastasisSpectrometry, Mass, Electrospray Ionizationambient ionisationcancer researchlipidomicsmass spectrometry imagingmetabolic fingerprintsprimary cell lines

Identifiers

PMID39062995
PMCPMC11277125

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.